Boston, MA -- (SBWIRE) -- 08/19/2013 -- Global Markets Direct's pharmaceuticals report, "TaiGen Biotechnology Co., Ltd. - Product Pipeline Review - 2013" provides data on the TaiGen Biotechnology Co., Ltd.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, TaiGen Biotechnology Co., Ltd.'s corporate website, SEC filings, investor presentations and featured press releases, both from TaiGen Biotechnology Co., Ltd. and industry-specific third party sources, put together by Global Markets Direct's team.

View Full Report Details and Table of Contents

Scope

- TaiGen Biotechnology Co., Ltd. - Brief TaiGen Biotechnology Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of TaiGen Biotechnology Co., Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of TaiGen Biotechnology Co., Ltd. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the TaiGen Biotechnology Co., Ltd.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to Get This Report

- Evaluate TaiGen Biotechnology Co., Ltd.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of TaiGen Biotechnology Co., Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the TaiGen Biotechnology Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with TaiGen Biotechnology Co., Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of TaiGen Biotechnology Co., Ltd. and identify potential opportunities in those areas.

Companies Mentioned in this Report: TaiGen Biotechnology Co., Ltd.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Generex Biotechnology Corporation - Product Pipeline Review - 2013
- TaiGen Biotechnology Co., Ltd. - Product Pipeline Review - 2012
- Shenzhen Beike Biotechnology Co., Ltd. - Product Pipeline Review - 2013
- Hodgkin Lymphoma - Pipeline Review, H2 2013
- Neutropenia - Pipeline Review, H1 2013
- Cytomegalovirus (HHV-5) Infections - Pipeline Review, H2 2013
- Dementia - Pipeline Review, H1 2013
- Fibrosis - Pipeline Review, H1 2013
- Chemotherapy Induced Neutropenia - Pipeline Review, H1 2013
- Anthrax - Pipeline Review, H1 2013